• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Blood Grouping Reagents Market Share

    ID: MRFR/HC/9241-CR
    142 Pages
    Rahul Gotadki
    November 2021

    Blood Grouping Reagents Market Research Report Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, ...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Blood Grouping Reagents Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Blood Grouping Reagents Market Share Analysis

    Blood grouping reagents encompass a range of crucial tests, including blood group assessments, phenotype evaluations, antibody screening, antigen typing, direct combos, and antibody identification. Crafting these products involves extensive research and rigorous clinical trials, aiming for efficiency and precision. The research and development (R&D) phase focuses on innovating new devices integrated with cutting-edge technology while enhancing existing equipment and kits. The ultimate goal is twofold: boosting efficiency and ensuring cost-effectiveness. In a market brimming with diverse products, companies strive to infuse innovative features into their pipelines, driving technological advancements. R&D is an intricate process demanding substantial expertise and skills. It commences with conceptualization, followed by meticulous product design, subsequent development, and culminating in rigorous product testing. Throughout this journey, the R&D team diligently refines new technologies to ensure precision and accuracy in test results. However, this journey is not solitary; it operates within the framework of stringent requirements set by regulatory bodies such as the US FDA and other regional regulatory authorities, ensuring that devices and drugs meet the mandated standards.

    This intricate process underscores the intricacies involved in the creation of blood grouping reagents, highlighting the industry's commitment to delivering accurate, reliable, and efficient products. From conceptualization through rigorous testing, each step demands precision and adherence to stringent regulatory standards. The amalgamation of technological innovation and adherence to regulatory benchmarks forms the bedrock of producing reliable blood grouping reagents indispensable to healthcare diagnostics and treatment.

    Once product strategies are finalized, the manufacturing phase kicks off, marking the inception of product realization. This manufacturing journey initiates with the gathering and assembly of raw materials, orchestrating the production of devices, kits, and related products either in-house or through collaborations with third-party manufacturers. Raw material procurement stands as an initial and pivotal phase within the manufacturing process, particularly crucial in crafting consumables and instruments integral to blood grouping reagents. Additionally, seeking cost-effective alternatives for pricey raw materials becomes imperative to streamline the manufacturing costs. Manufacturing operations are characterized by swiftness, swiftly transitioning to testing phases. Consequently, market players prioritize initiatives aimed at reducing production costs, underscoring the industry's concerted efforts to optimize expenses without compromising on quality or efficiency.

    Market Summary

    As per Market Research Future Analysis, the global Blood Grouping Reagents Market is projected to reach USD 0.0020 billion by 2032, growing at a CAGR of 7.6% from 2023 to 2032. The market was valued at USD 1,578.78 million in 2020. Blood grouping reagents are essential for identifying blood types based on antigens present on red blood cells. The market is driven by the rising prevalence of chronic disorders and increased spending on medical research, although concerns regarding the efficiency of test kits pose challenges. The COVID-19 pandemic has further amplified the demand for blood grouping reagents due to the surge in diagnostic testing requirements. The market is segmented by product, technique, test type, end user, and region, with significant growth opportunities in automated blood grouping devices.

    Key Market Trends & Highlights

    Key trends influencing the Blood Grouping Reagents Market include technological advancements and increasing demand for automation.

    • Market size in 2020: USD 1,578.78 million. Projected market size by 2032: USD 0.0020 billion. CAGR during 2023-2032: 7.6%. Anemia affects over 1.62 billion people globally, driving reagent demand.

    Market Size & Forecast

    2020 Market Size USD 1,578.78 million
    2032 Market Size USD 0.0020 billion
    CAGR 7.6%
    Largest Regional Market North America

    Major Players

    <p>Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Grifols SA (Spain), Immucor, Inc (US)</p>

    Market Trends

    <p>The ongoing advancements in blood grouping reagents are likely to enhance diagnostic accuracy and improve patient outcomes in transfusion medicine.</p>

    U.S. Food and Drug Administration (FDA)

    Blood Grouping Reagents Market Market Drivers

    Market Trends and Projections

    Regulatory Support for Blood Safety

    Regulatory bodies worldwide are increasingly emphasizing the importance of blood safety, which significantly impacts the Global Blood Grouping Reagents Market Industry. Stringent regulations regarding blood testing and safety protocols necessitate the use of high-quality reagents for accurate blood typing. Compliance with these regulations ensures that healthcare providers can deliver safe transfusions, thereby enhancing patient outcomes. As regulations evolve, the market is likely to adapt, leading to innovations in reagent development. This regulatory landscape not only supports market growth but also reinforces the commitment to patient safety in transfusion practices.

    Rising Demand for Blood Transfusions

    The Global Blood Grouping Reagents Market Industry experiences a notable increase in demand for blood transfusions, driven by a growing prevalence of chronic diseases and surgical procedures. As healthcare systems worldwide expand their capabilities, the need for accurate blood typing becomes paramount. In 2024, the market is projected to reach 0.11 USD Billion, reflecting the urgency for reliable reagents in transfusion medicine. This trend is expected to continue, with the market adapting to the rising number of transfusions required annually, thereby enhancing the overall efficiency of blood banks and hospitals.

    Increasing Awareness of Blood Donation

    The Global Blood Grouping Reagents Market Industry benefits from heightened awareness regarding the importance of blood donation. Campaigns aimed at educating the public about the need for diverse blood types have led to increased participation in blood donation drives. This surge in donations necessitates the use of effective blood grouping reagents to ensure compatibility and safety. As more individuals engage in donating blood, the demand for reliable reagents is expected to rise, thereby supporting the growth of the market. This trend underscores the critical role of education in fostering a culture of donation.

    Market Challenges and Declining Growth Rates

    Despite the growth potential, the Global Blood Grouping Reagents Market Industry faces challenges that may hinder its expansion. Projections indicate a compound annual growth rate (CAGR) of -29.29% for the period from 2025 to 2035, suggesting a decline in market activity. Factors contributing to this trend may include saturation in certain regions and the emergence of alternative technologies. As the market navigates these challenges, stakeholders must adapt their strategies to maintain relevance and ensure sustainability in a rapidly changing healthcare landscape.

    Technological Advancements in Blood Grouping

    Technological innovations play a crucial role in shaping the Global Blood Grouping Reagents Market Industry. The introduction of automated blood grouping systems and advanced reagents enhances accuracy and reduces turnaround times in blood typing processes. These advancements not only improve patient safety but also streamline laboratory workflows. As healthcare facilities increasingly adopt these technologies, the market is likely to witness a surge in demand for high-quality reagents. This trend indicates a shift towards more sophisticated blood grouping solutions, which could potentially lead to a more efficient healthcare delivery system.

    Market Segment Insights

    Regional Insights

    Key Companies in the Blood Grouping Reagents Market market include

    Industry Developments

    • In July 2020, Merck KGaA invested 18 million euros in new life science laboratory in Switzerland. The laboratory facility is to be built in Buchs (Switzerland) to support the growth of the company in the reference materials.
    • In April 2018, Quotient Limited received FDA approval for U.S. commercialization of seven new blood bank reagents.
    • In December 2017, Beckman Coulter, Inc. expanded its development & manufacturing facility based in Lismeehan, County Clare (Ireland). At this facility, the company develops and manufactures reagents used in clinical chemistry, hematology, and immunochemistry product.

    Future Outlook

    Blood Grouping Reagents Market Future Outlook

    <p>The Blood Grouping Reagents Market is projected to experience a -29.29% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for blood transfusions, and regulatory changes.</p>

    New opportunities lie in:

    • <p>Develop innovative, cost-effective reagents to enhance market penetration. Leverage digital platforms for efficient distribution and customer engagement. Invest in R&amp;D for next-generation blood grouping technologies to gain competitive edge.</p>

    <p>By 2035, the market is expected to stabilize, adapting to evolving healthcare demands and technological advancements.</p>

    Market Segmentation

    Report Overview

    Market Segmentation:

    Report Scope

    Report Attribute/MetricDetails
      Market Size  0.0020 Billion
      CAGR  7.6%
      Base Year  2021
      Forecast Period  2023-2032
      Historical Data  2020
      Forecast Units  Value (USD Billion)
      Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered  Products, Technique, Test Type, End User, and Region
      Geographies Covered  North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors  Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France), and others
      Key Market Opportunities  • Emergence of automated medical devices
      Key Market Drivers  • Increasing prevalence of chronic disorders • Increasing spending in medical research

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    How Big is the blood grouping reagents market?

    Blood Grouping Reagents Market size is projected to be worth USD 0.0020 billion at CAGR of 7.6% during the forecast period (2023 - 2032), The market was valued at USD 1,578.78 million in 2020.

    Who are the key players in the market of blood grouping reagents?

    Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France) are the key players in the market of blood grouping reagents

    Which region is predicted to lead the market of blood grouping reagents?

    North America holds the largest share in the global market of lood grouping reagents

    What is the major market driver of blood grouping reagents?

    Increasing prevalence of chronic disorders and Increasing spending in medical research are the major market driver of blood grouping reagents

    Which factors may limit the market growth of blood grouping reagents?

    Concern pertaining to the efficiency and accuracy of test kits may limit the market growth of blood grouping reagents

    1. List of Tables and Figures
      1. Table FIGURE 1 MARKET SYNOPSIS FIGURE 2 MARKET STRUCTURE: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES FIGURE 4 MARKET DYNAMICS: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 5 DRIVERS: IMPACT ANALYSIS FIGURE 6 RESTRAINT: IMPACT ANALYSIS FIGURE 7 VALUE CHAIN: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 9 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2020 & 2030 (USD MILLION) FIGURE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2020 & 2030 (USD MILLION) FIGURE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2020 & 2030 (USD MILLION) FIGURE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2020 & 2030 (USD MILLION) FIGURE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION 2020 & 2030 (USD MILLION) FIGURE 14 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY 2020 (%) FIGURE 15 EUROPE: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020 FIGURE 16 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020 FIGURE 17 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY REGION, 2020 FIGURE 18 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS FIGURE 20 REVENUE OF MAJOR PLAYERS, 2020 FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE 2020 FIGURE 22 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 23 MERCK KGAA: SWOT ANALYSIS FIGURE 24 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 25 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS FIGURE 26 NOVACYT GROUP: FINANCIAL OVERVIEW SNAPSHOT FIGURE 27 ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 ORTHO CLINICAL DIAGNOSTICS: SWOT ANALYSIS FIGURE 29 GRIFOLS SA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 GRIFOLS SA: SWOT ANALYSIS FIGURE 31 IMMUCOR, INC.: SWOT ANALYSIS FIGURE 32 QUOTIENT LTD: FINANCIAL OVERVIEW SNAPSHOT FIGURE 33 QUOTIENT LTD: SWOT ANALYSIS
    2. Table FIGURE 1 MARKET SYNOPSIS FIGURE 2 MARKET STRUCTURE: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES FIGURE 4 MARKET DYNAMICS: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 5 DRIVERS: IMPACT ANALYSIS FIGURE 6 RESTRAINT: IMPACT ANALYSIS FIGURE 7 VALUE CHAIN: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 9 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2020 & 2030 (USD MILLION) FIGURE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2020 & 2030 (USD MILLION) FIGURE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2020 & 2030 (USD MILLION) FIGURE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2020 & 2030 (USD MILLION) FIGURE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION 2020 & 2030 (USD MILLION) FIGURE 14 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY 2020 (%) FIGURE 15 EUROPE: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020 FIGURE 16 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020 FIGURE 17 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY REGION, 2020 FIGURE 18 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS FIGURE 20 REVENUE OF MAJOR PLAYERS, 2020 FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE 2020 FIGURE 22 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 23 MERCK KGAA: SWOT ANALYSIS FIGURE 24 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT FIGURE 25 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS FIGURE 26 NOVACYT GROUP: FINANCIAL OVERVIEW SNAPSHOT FIGURE 27 ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT FIGURE 28 ORTHO CLINICAL DIAGNOSTICS: SWOT ANALYSIS FIGURE 29 GRIFOLS SA: FINANCIAL OVERVIEW SNAPSHOT FIGURE 30 GRIFOLS SA: SWOT ANALYSIS FIGURE 31 IMMUCOR, INC.: SWOT ANALYSIS FIGURE 32 QUOTIENT LTD: FINANCIAL OVERVIEW SNAPSHOT FIGURE 33 QUOTIENT LTD: SWOT ANALYSIS

    Blood Grouping Reagents Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027